Staar Surgical Co.

STAAR Surgical designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company is a manufacturer of lenses used worldwide in corrective or refractive surgery. The company's principal products are implantable Collamer lenses (ICLs) used in refractive surgery and intraocular lenses (IOLs) used in cataract surgery. ICLs, consisting of the company's ICL family of products, including the Toric implantable Collamer lenses and EVO+ Visian ICL, are intraocular lenses used to correct refractive conditions. IOLs are prosthetic intraocular lenses used to restore vision that has been affected by cataracts.
  • TickerSTAA
  • ISINUS8523123052
  • ExchangeNASDAQ Stock Market
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Staar Surgical Co: 1 director sold

A director at Staar Surgical Co sold 11,387 shares at 72.460USD and the significance rating of the trade was 95/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of bo...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

MarketLine Department

Second Sight Medical Products, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Second Sight Medical Products, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Second Sight Medical Products, Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to su...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500 bullish but currently extended; Downgrading Financials The S&P 500's 5-month uptrend remains intact, and as long as it continues we are in the bull camp. With that said, we are near the top end of the uptrend channel and could fall 2.75%-3.25% before we get to uptrend support... see chart below. Overall we believe the positives outweigh the concerns as highlighted below: • Positives: (1) Tech, Discretionary, Health Care/biotech, and the Nasdaq are reasserting leadership and are at new price highs; (2) Large-caps (S&P 500) and small-caps (S&P 600) are also at new highs with uptrends...

Staar Surgical Co: 1 director sold

A director at Staar Surgical Co sold 11,387 shares at 72.460USD and the significance rating of the trade was 95/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of bo...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

MarketLine Department

Second Sight Medical Products, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Second Sight Medical Products, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Second Sight Medical Products, Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to su...

Valens Research

UAFRS vs As Reported Monthly Highlights - 2020 02 29

This month, Valens identified distortions and the corresponding adjustments to correct for those distortions for IRM, STAA, DRI, GWRE, GRMN and RB.:GBR.

Valens Research

UAFRS vs As Reported Weekly Highlights - 2020 02 06

This week, Valens identified distortions and the corresponding adjustments to correct for those distortions for EW, STAA, and BOO:GPR.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch